Medical Training AITirzepatide Protocols for Weight Loss
You'll be able to evaluate patient candidacy, structure a titration plan, and manage side effects and follow-up for tirzepatide therapy.
What this track covers
This track covers dual GIP/GLP-1 receptor agonism and its metabolic effects, patient selection and contraindications, dosing and titration strategy, and ongoing monitoring for weight management therapy. It's designed for clinicians who prescribe or co-manage patients on incretin-based weight loss agents and want a structured way to reason through protocol decisions.
What you will practice
- Screen a patient's history for contraindications and comorbidities before initiating therapy
- Walk through a titration schedule and identify when to hold or slow escalation
- Recognize and triage common GI side effects versus signs requiring escalation of care
- Build a monitoring and follow-up cadence for a patient on maintenance dosing
- Discuss a plan for long-term management, including weight regain risk
Simulator scenario
A simulated follow-up visit with a patient reporting GI side effects during dose escalation, requiring the clinician to decide whether to hold, adjust, or continue titration.
Board question topics
- Mechanism of dual GIP/GLP-1 receptor agonism
- Patient selection and contraindications
- Titration and dose adjustment scenarios
- Monitoring and long-term management planning
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free